0001567619-22-004750.txt : 20220216 0001567619-22-004750.hdr.sgml : 20220216 20220216175204 ACCESSION NUMBER: 0001567619-22-004750 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220215 FILED AS OF DATE: 20220216 DATE AS OF CHANGE: 20220216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kiraly Thomas E CENTRAL INDEX KEY: 0001623986 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 22644906 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE, SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER, INC. CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 doc1.xml FORM 4 X0306 4 2022-02-15 0 0000722723 HANGER, INC. HNGR 0001623986 Kiraly Thomas E 10910 DOMAIN DRIVE SUITE 300 AUSTIN TX 78758 0 1 0 0 EVP & Chief Financial Officer Common Stock 2022-02-15 4 A 0 13842 0 D 255917 D Stock Options (right to buy) 12.77 2027-05-19 Common Stock 62778 31389 D Represents performance shares being issued to the reporting person based on the achievement of performance targets for the period beginning January 1, 2021 and ending on December 31, 2021. These performance shares vest in equal tranches over a four year period, commencing on the first anniversary of the grant date. Includes (i) unvested restricted shares totaling 13,842 shares of stock from an initial grant of 13,842 shares of restricted stock which begins to vest on March 8, 2022; (ii) unvested restricted shares totaling 17,435 shares of stock from an initial grant of 17,435 shares of restricted stock which begins to vest on March 8, 2022; (iii) unvested restricted shares totaling 13,094 shares of stock from an initial grant of 14,523 shares of restricted stock made on March 9, 2020; (iv) unvested restricted shares totaling 15,404 shares of stock from an initial grant of 17,085 shares of restricted stock made on March 9, 2020; [continued in next footnote] (v) unvested restricted shares and fully vested shares totaling 10,546 shares of stock from an initial grant of 16,185 shares of restricted stock made on March 8, 2019; (vi) unvested restricted shares and fully vested shares totaling 12,499 shares of stock from an initial grant of 19,181 shares of restricted stock made on March 8, 2019; (vii) unvested restricted shares and fully vested shares totaling 11,605 shares of stock from an initial grant of 18,622 shares of restricted stock made on March 9, 2018; (viii) unvested restricted shares and fully vested shares totaling 12,924 shares of stock from an initial grant of 26,250 shares of restricted stock, the remainder of which vested on March 8, 2021; [continued in next footnote] (ix) unvested restricted shares and fully vested shares totaling 12,950 shares of stock from an initial grant of 23,408 shares of restricted stock made on March 8, 2018; (x) fully vested shares totaling 16,887 shares of stock from an initial grant of 23,844 shares of restricted stock made on March 6, 2015; (xi) unvested restricted shares and fully vested shares totaling 12,308 shares of stock from an initial grant of 25,000 shares of restricted stock made on March 8, 2017; (xii) fully vested shares totaling 3,182 shares of stock from an initial grant of 5,000 shares of restricted stock made on October 11, 2016; [continued in next footnote] (xiii) unvested restricted shares and fully vested shares totaling 13,096 shares of stock from an initial grant of 25,000 shares of restricted stock April 29, 2016; (xiv) fully vested shares totaling 12,037 shares of stock from an initial grant of 15,896 shares of restricted stock made on March 6, 2015 and (xv) fully vested shares totaling 35,064 shares of stock from an initial grant of 49,660 shares of restricted stock made on October 1, 2014. Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020. Jessica Lochmann Allen, Attorney-in-Fact for Thomas E. Kiraly 2022-02-16